$2.71
0.207.97%
In chiusura: -
$2.71
0.000100.00%
After hour: 6:18 PM EDT
Comments
Loading...
Attività di insider trading
Tieni traccia delle ultime attività di insider trading Gossamer Bio. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Gossamer Bio.
Cos'è l'attività interna?
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Cosa stanno facendo gli Gossamer Bio Inc addetti ai lavori?
Gli addetti ai lavori non hanno segnalato acquisti/vendite negli ultimi 30 giorni.
Notevoli acquisti e vendite recenti di insider
- Il giorno agosto 20, 2025, Sandra Milligan, l'azienda DIRECTOR purchased 26.05K condivisioni per $1.92 ciascuna.
Statistiche sulla proprietà per Gossamer Bio Inc
Numero di azioni emesse
231.456M
Azioni possedute dagli insider
2.833M
Percentuale posseduta dagli Insider
1.24%
Azioni possedute dagli investitori istituzionali
48.229M
Percentuale posseduta dagli investitori istituzionali
20.8%
Aug 20, 2025 | DIRECTOR | 26.05K | $1.92 | $50.02K | BUY | 81.41% | 58.05K | Aug 19 | ||
Jun 25, 2024 | CHIEF MEDICAL OFFICER | -1.91K | $0.66 | -$1.26K | SELL | -0.95% | 199.43K | Jun 24 | ||
Jun 24, 2024 | PRESIDENT & CEO | 372.00K | $0.67 | $250.28K | BUY | 7.21% | 5.53M | Jun 21 | ||
Jun 20, 2024 | COO/CFO | 100.00K | $0.59 | $59.11K | BUY | 26.32% | 480.01K | Jun 18 | ||
Jun 20, 2024 | CHIEF COMMERCIAL OFFICER | 25.00K | $0.60 | $15.05K | BUY | ∞ | 25.00K | Jun 17 | ||
Mar 28, 2024 | EVP, TECH OPS AND ADMIN | -6.43K | $1.16 | -$7.43K | SELL | -1.05% | 608.16K | Mar 27 | ||
Mar 28, 2024 | COO/CFO | -6.43K | $1.16 | -$7.43K | SELL | -1.34% | 472.75K | Mar 27 | ||
Mar 28, 2024 | PRESIDENT & CEO | -23.17K | $1.16 | -$26.77K | SELL | -0.45% | 5.16M | Mar 27 | ||
Mar 19, 2024 | CHIEF MEDICAL OFFICER | -4.02K | $1.33 | -$5.34K | SELL | -1.98% | 198.80K | Mar 18 | ||
Mar 19, 2024 | EVP, REGULATORY AFFAIRS | -4.02K | $1.33 | -$5.34K | SELL | -7.46% | 49.83K | Mar 18 | ||
Nov 17, 2023 | DIRECTOR | 32.00K | $0.79 | $25.21K | BUY | ∞ | 32.00K | Nov 15 | ||
Nov 14, 2023 | COO/CFO | 200.00K | $0.56 | $112.88K | BUY | 71.64% | 479.18K | Nov 13 | ||
Jun 26, 2023 | CHIEF MEDICAL OFFICER | -1.81K | $1.29 | -$2.34K | SELL | -0.90% | 200.11K | Jun 22 | ||
Apr 05, 2023 | COO/CFO | 55.00K | $1.02 | $56.09K | BUY | 32.32% | 225.16K | Apr 04 | ||
Mar 22, 2023 | EVP, TECH OPS AND ADMIN | 18.50K | $1.20 | $22.14K | BUY | 51.23% | 54.61K | Mar 20 | ||
Mar 22, 2023 | COO/CFO | 50.00K | $0.97 | $48.44K | BUY | 41.61% | 170.16K | Mar 20 | ||
Mar 22, 2023 | PRESIDENT & CEO | 878.57K | $1.14 | $1.00M | BUY | 23.36% | 4.64M | Mar 20 - Mar 22 | ||
Mar 20, 2023 | CHIEF SCIENTIFIC OFFICER | -6.03K | $1.10 | -$6.62K | SELL | -7.33% | 76.26K | Mar 16 | ||
Mar 20, 2023 | CHIEF MEDICAL OFFICER | -7.56K | $1.10 | -$8.30K | SELL | -3.61% | 201.93K | Mar 16 | ||
Mar 20, 2023 | EVP, REGULATORY AFFAIRS | -7.56K | $1.10 | -$8.31K | SELL | -12.32% | 53.85K | Mar 16 | ||
Oct 25, 2022 | EVP, REGULATORY AFFAIRS | -4.76K | $12.07 | -$57.43K | SELL | -7.19% | 61.41K | Oct 24 | ||
Oct 25, 2022 | CHIEF SCIENTIFIC OFFICER | -4.88K | $12.07 | -$58.87K | SELL | -5.59% | 82.29K | Oct 24 | ||
Oct 25, 2022 | CHIEF MEDICAL OFFICER | -4.76K | $12.07 | -$57.43K | SELL | -2.24% | 207.97K | Oct 24 | ||
Jul 15, 2022 | CHIEF SCIENTIFIC OFFICER | 6.93K | $7.21 | $49.99K | BUY | 8.64% | 87.17K | Jul 15 | ||
Jul 15, 2022 | EVP, TECH OPS AND ADMIN | 6.93K | $7.21 | $49.99K | BUY | 23.77% | 36.11K | Jul 15 | ||
Jul 15, 2022 | COO/CFO | 13.87K | $7.21 | $100.00K | BUY | 13.05% | 120.16K | Jul 15 | ||
Jul 15, 2022 | PRESIDENT & CEO | 138.70K | $7.21 | $1000.00K | BUY | 3.83% | 3.76M | Jul 15 | ||
Jul 05, 2022 | CHIEF SCIENTIFIC OFFICER | -8.81K | $8.25 | -$72.65K | SELL | -9.89% | 80.23K | Jul 01 | ||
Jun 23, 2022 | CHIEF MEDICAL OFFICER | -1.78K | $6.88 | -$12.23K | SELL | -0.83% | 212.44K | Jun 22 | ||
May 05, 2022 | CHIEF SCIENTIFIC OFFICER | -1.26K | $7.20 | -$9.09K | SELL | -1.40% | 89.04K | May 04 | ||
Mar 24, 2022 | EVP, TECH OPS AND ADMIN | -10.72K | $8.91 | -$95.59K | SELL | -1.75% | 601.23K | Mar 23 | ||
Mar 24, 2022 | PRESIDENT & CEO | -19.04K | $8.91 | -$169.70K | SELL | -0.52% | 3.62M | Mar 23 | ||
Mar 24, 2022 | COO/CFO | -10.72K | $8.91 | -$95.59K | SELL | -9.16% | 106.29K | Mar 23 | ||
Mar 17, 2022 | CHIEF SCIENTIFIC OFFICER | -5.00K | $8.28 | -$41.41K | SELL | -5.25% | 90.30K | Mar 16 | ||
Mar 17, 2022 | EVP, REGULATORY AFFAIRS | -6.28K | $8.28 | -$51.98K | SELL | -8.67% | 66.17K | Mar 16 | ||
Mar 17, 2022 | CHIEF MEDICAL OFFICER | -6.28K | $8.28 | -$51.98K | SELL | -2.85% | 214.21K | Mar 16 | ||
Oct 26, 2021 | EVP, REGULATORY AFFAIRS | -2.38K | $12.25 | -$29.12K | SELL | -3.18% | 72.45K | Oct 25 | ||
Oct 26, 2021 | CHIEF SCIENTIFIC OFFICER | -2.38K | $12.25 | -$29.12K | SELL | -2.43% | 95.31K | Oct 25 | ||
Oct 26, 2021 | CHIEF MEDICAL OFFICER | -2.38K | $12.25 | -$29.12K | SELL | -1.07% | 219.97K | Oct 25 | ||
Mar 25, 2021 | CHIEF SCIENTIFIC OFFICER | -5.49K | $9.48 | -$52.05K | SELL | -2.60% | 206.06K | Mar 23 | ||
Mar 25, 2021 | CHIEF FINANCIAL OFFICER | -5.49K | $9.48 | -$52.05K | SELL | -4.48% | 117.01K | Mar 23 | ||
Mar 25, 2021 | EVP & GENERAL COUNSEL | -5.49K | $9.48 | -$52.05K | SELL | -0.89% | 610.42K | Mar 23 | ||
Oct 14, 2020 | — | 2.50K | $9.53 | $23.82K | PURCHASE | 9.37% | 29.18K | Oct 14 | ||
Oct 14, 2020 | DIRECTOR | 96.52K | $10.36 | $1000.00K | BUY | 2.85% | 3.48M | Oct 14 | ||
Oct 14, 2020 | — | 3.00K | $10.01 | $30.04K | PURCHASE | 4.03% | 77.50K | Oct 14 | ||
Jun 23, 2020 | — | 2.00K | $12.96 | $25.92K | PURCHASE | 2.76% | 74.50K | Jun 23 | ||
Dec 31, 2019 | CHIEF MEDICAL OFFICER | 0.00 | $12.87 | -$181.78K | SELL-OPTIONS | 0.00% | 0.00 | Dec 27 - Dec 30 | ||
Sep 27, 2019 | EVP & GENERAL COUNSEL | 1.00K | $16.65 | $16.65K | BUY | 3.89% | 26.68K | Sep 27 | ||
Sep 27, 2019 | DIRECTOR | 10.00K | $16.80 | $167.98K | BUY | 0.30% | 3.38M | Sep 27 | ||
Sep 27, 2019 | PRESIDENT & CEO | 10.00K | $16.80 | $167.98K | BUY | 0.25% | 4.05M | Sep 27 | ||
Sep 26, 2019 | CHIEF FINANCIAL OFFICER | 1.12K | $16.78 | $18.81K | BUY | 4.51% | 26.00K | Sep 26 | ||
Sep 23, 2019 | 10% OWNER | -183.61K | $21.96 | -$4.03M | SELL | -2.73% | 6.55M | Sep 20 | ||
Sep 18, 2019 | 10% OWNER | -82.21K | $21.75 | -$1.79M | SELL | -1.21% | 6.74M | Sep 16 - Sep 18 | ||
Sep 12, 2019 | DIRECTOR | -112.78K | $21.22 | -$2.39M | SELL | -1.63% | 6.82M | Sep 10 - Sep 11 | ||
Sep 09, 2019 | DIRECTOR | -21.40K | $21.56 | -$461.54K | SELL | -0.31% | 6.93M | Sep 05 - Sep 06 | ||
Aug 29, 2019 | CHIEF SCIENTIFIC OFFICER | -50.00K | $19.88 | -$994.04K | SELL | -28.73% | 124.06K | Aug 28 - Aug 29 | ||
Jun 03, 2019 | CHIEF FINANCIAL OFFICER | 1.00K | $18.70 | $18.70K | BUY | 4.19% | 24.88K | May 30 | ||
Feb 12, 2019 | DIRECTOR | 7.20K | $16.00 | $115.20K | BUY | ∞ | 7.20K | Feb 12 | ||
Feb 12, 2019 | EVP & GENERAL COUNSEL | 5.00K | $16.00 | $24.80K | BUY | 0.96% | 523.72K | Feb 12 | ||
Feb 12, 2019 | CHIEF FINANCIAL OFFICER | 23.88K | $16.00 | $96.00K | BUY | ∞ | 23.88K | Feb 12 |
FAQ
L'insider trading è legale?
L'insider trading è legale a condizione che gli insider segnalino le loro operazioni alla SEC. Il trading illegale di titoli si verifica quando l'insider viola un dovere fiduciario o non segnala le sue operazioni.
Quali sono alcuni esempi di manipolazione del mercato?
L'insider trading, gli schemi di pump and dump, il front running e i wash trade sono tutti esempi di manipolazione del mercato. Gli investitori che seguono i movimenti delle attività degli insider dovrebbero riflettere attentamente sul motivo per cui questi insider stanno negoziando le loro azioni prima di procedere.
Sfoglia insider trading su tutte le azioni.